DiagnosisONE landed a $5 million investment from a New Jersey venture capital firm to build out its sales, marketing and development operations.
The Nashua, N.H.-based company makes software to help healthcare providers manage diagnostics data.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
DiagnosisONE landed a $5 million investment from a New Jersey venture capital firm to build out its sales, marketing and development operations.
The Nashua, N.H.-based company makes software to help healthcare providers manage diagnostics data.
Johnson & Johnson (NYSE:JNJ) managed to post a 7.5 percent boost to its bottom line despite flat second-quarter sales, but saw its stock slide on lowered guidance from problems with its over-the-counter drug unit.
The New Brunswick, N.J.-based health products conglomerate’s medical device and diagnostics business posted sales of $6.13 billion, up 4.1 percent compared with $5.89 billion during the same period last year.
Joseph Lister, a British surgeon, established the founding principles of aseptic technique in the journal Lancet in 1867. Before then, surgeons did not wash their hands before operating or disinfect their surgical instruments. (Shudder.) In case you’ve ever sat up late at night pondering the origins of the word “Listerine,” you’ll be glad to learn it’s named after this important surgeon.
By Mary Vanac
Contract product developer and manufacturer New Product Innovations opened a gateway for U.S. medical device makers that want to do business in China.
By Thomas Lee
To improve healthcare in Minnesota, the state is now offering providers a little more than the proverbial pat on the back.
Earlier this month, Minnesota health officials launched an incentive-based payment system for hospitals and ambulatory firms who treat patients enrolled in the state’s health insurance programs.
Elemé Medical Inc. added $6.6 million to its coffers in a debt offering, according to a regulatory filing.
The Merrimack, N.H.-based cosmetic device maker raised the cash from nine un-named investors, according to the filing.
Epocrates Inc. plans to go public — again.
The company last week filed for an initial public offering that could bring in as much as $75 million, according to a Securities & Exchange Commission filing. Epocrates makes reference and interactive tools designed for both healthcare providers and patients for mobile platforms such as Google’s (NSDQ:GOOG) Android or Apple’s (NSDQ:AAPL) iPhone.
It’s the second stab at an IPO for the San Mateo, Calif.-based company, which filed for a $75 million offering in 2008 before pulling it back as the economy cratered.
Cardiac Science Corp. (NSDQ:CSCX) will replace 24,000 automated external defibrillators implicated in a November 2009 recall.
The Bothell, Wash.-based company’s Powerheart, CardioVive, Nihon Kohden and GE Responder AEDs have electrical component flaws that may cause device failures. The flaws could not be remedied through software patches, according to the Food & Drug Administration.
GE Capital’s Healthcare Financial Services division gave Mitralign Inc. a $5 million line of credit.
Mitralign is developing a catheter-based mitral valve repair device.
The Tewksbury, Mass.-based firm plans to use the loan as working capital, according to a press release.
Since the Final Meaningful Use and Standards Rules were released last week, many people have emailed me questions, which I’d like to share generally. My blog is not reviewed by ONC or CMS, so these answers are my own opinion.
NxStage Medical Inc. (NSDQ:NXTM) broadened its stake in the Italian dialysis market with a Spindial S.p.A. distribution deal.
The Lawrence, Mass.-based company inked a five-year agreement for renal care product distributor Spindial S.p.A. to sell NxStage’s System One hemodialysis treatment system in Italy.